Vimta Labs Limited (VIMTALABS) — Financial Results | 15 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Conference call scheduled for Q1 FY27 results discussion
💡 Investor Takeaway
Investors can attend the call to hear management discuss quarterly results.

Vimta Labs Limited announced an analyst and investor conference call on July 20, 2026 at 4:00 PM IST to discuss unaudited Q1 FY27 financial results, following SEBI regulatory requirements. The call details and access options are available on the company website.

📄 View Original Announcement (PDF)

About Vimta Labs Limited (VIMTALABS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹2,878.27 Cr P/E: 23.3 ROE: 19.2% ROCE: 24.3% Div Yield: 0.31%

View full VIMTALABS stock details →

📡 Get AI alerts when VIMTALABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIMTALABS — Free

📊 More VIMTALABS filings

See all VIMTALABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIMTALABS files new disclosures

Track VIMTALABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIMTALABS — Free

Free account · 2 AI queries/day